Dr. Vibhor Gupta is the founder of Pangaea and based in South San Francisco and London. Vibhor trained in oncology and has a breadth of experience in life sciences through his work in industry and academia over the last two decades. Prior to Pangaea, Vibhor started and built the European business for Quantum Secure, which was headquartered in Silicon Valley and was successfully acquired in 2015. Following Quantum Secure, Vibhor served as Senior Vice President of Commercial Strategy and Sales at Seven Bridges Genomics, which was founded at Harvard. Vibhor’s academic career focused on conducting molecular biology studies and building bioinformatics tools and machine learning models with epigenetic, genomic, transcriptomic and clinical trial data in the context of oncology and infectious diseases. Vibhor has access to an extensive global network in the Life sciences industry and is regularly invited to speak at international conferences, government funded programs and investment summits.

Infinitopes is a Cancer Research UK (CRUK) led spinout from Oxford University. We combine world leading expertise in Precision Immunomics antigen discovery, T-cell immunology, biomanufacturing, vaccinology, and oncology clinical trials. Our preclinical vaccines deliver 80% protection, vs control animals dying in three weeks. Lead candidate entering phase I/IIa in 2024.